+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Complicated Urinary Tract Infections - Epidemiology Forecast - 2034

  • PDF Icon

    Report

  • 119 Pages
  • March 2024
  • Region: Global
  • DelveInsight
  • ID: 5525280
UP TO OFF until Dec 31st 2024

Key Highlights

  • Urinary tract infections (UTIs) are amongst the most frequent bacterial infections. They can manifest clinically in various ways, from relatively benign, uncomplicated infections to complicated UTIs (cUTIs), pyelonephritis, and severe urosepsis. cUTI is a heterogeneous entity comprising multiple forms.
  • The clinical presentation of symptomatic infection in patients with complicated urinary infection varies across a wide spectrum, ranging from mild lower tract irritative symptoms, such as frequency and urgency, to severe systemic manifestations, such as bacteremia and sepsis. Complete urinary obstruction or trauma to the bacteriuric genitourinary tract, especially with hematuria, appears to be associated with more severe clinical presentations.
  • The diagnosis of a cUTI is based on three main features: the clinical picture, microbiological tests, and radiological investigations. The most common clinical presentations of UTI include acute cystitis, pyelonephritis, and less commonly acute prostatitis, but patients with abnormal urinary tracts can present more atypically. Ultrasound and CT scans may sometimes be useful or even critical for diagnosing a perinephric abscess, urinary retention, hydronephrosis, and obstructive pyelonephritis from stones in septic patients.
  • In the 7MM, the highest cases of age-specific cUTI were observed in the age group of 65-84 years, which were around 4,000,000 cases in 2023.
  • As per the analysis, the United States showed the highest number of diagnosed-incident cases of cUTI, accounting for nearly 42% of the diagnosed-incident cases of cUTI in the 7MM in 2023.
  • In 2023, approximately 200,000 cUTI incident cases progressed from uUTI in Japan.
The “Complicated Urinary Tract Infection (cUTI) - Epidemiology Forecast - 2034” report delivers an in-depth understanding of cUTI, historical and forecasted epidemiology in the United States, EU4 (Germany, France, Italy, and Spain) and the United Kingdom, and Japan.

cUTI Disease Understanding and Diagnostic Algorithm


cUTI Overview


Urinary tract infections (UTIs) are one of the most frequent infectious illnesses in the world, yet they remain understudied. Although uropathogenic E. coli (UPEC) accounts for a high percentage of UTIs, various bacteria, each of which will have its host-pathogen interactions with the bladder environment, can infect the urinary tract.

UTIs come in various clinical morphologies, ranging from relatively benign, uncomplicated infections to complicated UTIs (cUTIs), pyelonephritis, and severe urosepsis. As a result, the stratification of individuals with UTIs is critical. There are several categorization methods for UTIs, with the common reasoning that complicated UTIs have a greater risk of recurrence, chronification, progression, or catastrophic results than uncomplicated UTIs. Host factors, rather than pathogen characteristics, dictate the pathogenesis and management of cUTIs and pyelonephritis. High antibiotic resistance rates among causative microorganisms are linked to cUTIs and pyelonephritis.

cUTI Diagnosis

This diagnosis of a cUTI is based on three main features: the clinical picture, microbiological tests, and radiological investigations. Physicians should always consider atypical microbiology and the potential for urinary tract obstruction (UTO), which may require prompt drainage in this patient group.

The most common clinical presentations of UTI include acute cystitis, pyelonephritis, and less commonly acute prostatitis, but patients with abnormal urinary tracts can present more atypically. A carefully taken history is an essential diagnostic tool, with particular attention to the symptoms of frequency, dysuria, hematuria, suprapubic, and/or loin pain.

Basic laboratory tests may reveal elevated inflammatory markers, and renal function should be recorded. The urine dipstick is a simple and cheap bedside test and is very useful in confirming a diagnosis of UTI.

Radiological investigations are not helpful in the initial diagnosis of most infections limited to the genitourinary tract, as there should be sufficient clues from the history, physical examination, and laboratory results. Ultrasound and CT scans may sometimes be useful or even critical for diagnosing a perinephric abscess, urinary retention, hydronephrosis, and obstructive pyelonephritis from stones in septic patients.

cUTI Epidemiology


The cUTI epidemiology chapter in the report provides historical as well as forecasted epidemiology segmented by total diagnosed incident cases of cUTI, diagnosed incident cases of cUTI progressed from uUTI, age-specific cases, pathogen-specific cases, and total treated cases of cUTI in the United States, EU4 countries (Germany, France, Italy, Spain) and the United Kingdom, and Japan from 2020 to 2034.
  • In the 7MM, nearly 1,000,000 cUTI incident cases progressed from uUTI in the year 2023, which is expected to increase during the forecast period (2024-2034).
  • In the US, maximum number of cUTI cases were observed for the age group of 65-84 years, followed by =85 years.
  • Among the EU4 and the UK, Germany recorded the highest number of diagnosed-incident cases of cUTI with approximately 26% cases in 2023, which is estimated to rise by 2034, at a CAGR of 0.6%.
  • Japan accounted for around 800,000 cases of cUTI in 2023 caused due to Uropathogenic Escherichia coli, followed by 100,000 cases caused by Klebsiella pneumoniae.

Scope of the Report

  • The report covers a segment of key events, an executive summary, and a descriptive overview of cUTI, explaining its causes, signs and symptoms, pathogenesis, and currently available therapies.
  • Comprehensive insight into the epidemiology segments and forecasts, the future growth potential of diagnosis rate, and disease progression have been provided.
  • A detailed review of current challenges in establishing diagnosis and diagnosis rate is provided.

cUTI Report Insights

  • Patient Population
  • Total Diagnosed Incident Cases of cUTI, Diagnosed Incident Cases of cUTI Progressed From uUTI, Age-specific Cases, Pathogen-specific Cases, and Total Treated Cases of cUTI
  • Country-wise Epidemiology Distribution

cUTI Report Key Strengths

  • Eleven-year Forecast
  • The 7MM Coverage
  • cUTI Epidemiology Segmentation

cUTI Report Assessment

  • Epidemiology Segmentation
  • Current Diagnostic Practices

Key Questions

Epidemiology Insights

  • What are the disease risk, burdens, and unmet needs of cUTI? What will be the growth opportunities across the 7MM with respect to the patient population pertaining to cUTI?
  • What is the historical and forecasted cUTI patient pool in the United States, EU4 (Germany, France, Italy, Spain) and the United Kingdom, and Japan?
  • What is the diagnostic pattern of cUTI?
  • Which clinical factors will affect cUTI?
  • Which factors will affect the increase in the diagnosis of cUTI?

Reasons to buy

  • Insights on disease burden, details regarding diagnosis, and factors contributing to the change in the epidemiology of the disease during the forecast years.
  • To understand the change in cUTI cases in varying geographies over the coming years.
  • Detailed overview on total diagnosed incident cases of cUTI, diagnosed incident cases of cUTI progressed from uUTI, age-specific cases, pathogen-specific cases, and total treated cases of cUTI is included.
  • To understand the perspective of key opinion leaders around the current challenges with establishing the diagnosis and insights on the treatment-eligible patient pool.
  • Detailed insights on various factors hampering disease diagnosis and other existing diagnostic challenges.

Table of Contents

1. Key Insights2. Report Introduction
3. Complicated Urinary Tract Infection (cUTI) Market Overview at a Glance
3.1. Patient Share (%) Distribution of cUTI by Therapies in the 7MM in 2024
3.2. Patient Share (%) Distribution of cUTI by Therapies in the 7MM in 2034
4. Executive Summary of Complicated Urinary Tract Infection (cUTI)5. Key Events
6. Disease Background and Overview
6.1. Introduction
6.2. Classification of UTI
6.3. Signs and Symptoms of cUTIs
6.4. Risk Factors and Causes
6.5. Pathophysiology of cUTIs
6.6. Complications
6.7. Diagnosis of cUTIs
6.7.1. Differential diagnosis (DDx)
6.8. Diagnostic Guidelines for Complicated Urinary Tract Infection
6.8.1. The European Association of Urology Guidelines for Diagnosis of cUTIs
6.8.2. Infectious Diseases Society of America (IDSA) Guidelines for the Diagnosis and Treatment of Asymptomatic Bacteriuria (ASB) in Adults
6.8.3. NICE Guidelines for diagnosis of UTI in infants and children
7. Methodology
8. Epidemiology and Patient Population
8.1. Key Findings
8.2. Assumptions and Rationale
8.3. The 7MM
8.3.1. Total Diagnosed Incident Cases of Complicated Urinary Tract Infection (cUTI) in the 7MM
8.3.2. Total Diagnosed Incident Cases of cUTI Progressed from uUTI in the 7MM
8.4. The United States
8.4.1. Total Diagnosed Incident Cases of Complicated Urinary Tract Infection in the US
8.4.2. Total Diagnosed Incident Cases of cUTI Progressed from uUTI in the US
8.4.3. Total Age-specific Cases of Complicated Urinary Tract Infection
8.4.4. Total Pathogen-specific Cases of Complicated Urinary Tract Infection
8.4.5. Total Treated Case of Complicated Urinary Tract Infection
8.5. EU4 and the UK
8.5.1. Total Diagnosed Incident Cases of Complicated Urinary Tract Infection in EU4 and the UK
8.5.2. Total Diagnosed-Incident Cases of cUTI Progressed from uUTI in EU4 and the UK
8.5.3. Total Age-specific Cases of Complicated Urinary Tract Infection in EU4 and the UK
8.5.4. Total Pathogen-specific Cases of Complicated Urinary Tract Infection in EU4 and the UK
8.5.5. Total Treated Cases of Complicated Urinary Tract Infection in EU4 and the UK
8.6. Japan
8.6.1. Total Diagnosed Incident Cases of Complicated Urinary Tract Infection (cUTI) in Japan
8.6.2. Total Diagnosed Incident Cases of cUTI progressed from uUTI in Japan
8.6.3. Total Age-specific Cases of Complicated Urinary Tract Infection in Japan
8.6.4. Total Pathogen-specific Cases of Complicated Urinary Tract Infection in Japan
8.6.5. Total Treated Cases of Complicated Urinary Tract Infection in Japan
9. Appendix
9.1. Acronyms and Abbreviations
9.2. Report Methodology
9.3. Bibliography
10. Publisher Capabilities11. Disclaimer12. About the Publisher
List of Tables
Table 1: Summary of Complicated Urinary Tract Infection (cUTI) Epidemiology (2020-2034)
Table 2: Organisms commonly found infecting cUTI patients
Table 3: Total Diagnosed Incident Cases of cUTI (in Thousands) in the 7MM(2020-2034)
Table 4: Total Diagnosed-Incident Cases of cUTI progressed from uUTI (in Thousands) in the 7MM (2020-2034)
Table 5: Total Diagnosed Incident Cases of cUTI in the US (in Thousands) (2020-2034)
Table 6: Total Diagnosed Incident Cases of cUTI progressed from uUTI (in Thousands) in the US (2020-2034)
Table 7: Total Age-specific Cases of cUTI (in Thousands) in the US (2020-2034)
Table 8: Total Pathogen-specific Cases of cUTI (in Thousands) in the US (2020-2034)
Table 9: Total Treated Cases of cUTI (in Thousands) in the US (2020-2034)
Table 10: Total Diagnosed-Incident Cases of cUTI (in Thousands) in EU4 and the UK (2020-2034)
Table 11: Total Diagnosed Incident Cases of cUTI progressed from uUTI (in Thousands) in EU4 and the UK (2020-2034)
Table 12: Total Age-specific Cases of Complicated Urinary Tract Infection in EU4 and the UK (in Thousands) (2020-2034)
Table 13: Total Pathogen-specific Cases of Complicated Urinary Tract Infection (in Thousands) in EU4 and the UK (2020-2034)
Table 14: Total Treated Cases of cUTI in EU4 and the UK (in Thousands) (2020-2034)
Table 15: Total Diagnosed-Incident Cases of cUTI (in Thousands) in Japan (2020-2034)
Table 16: Total Diagnosed Incident Cases of cUTI progressed from uUTI (in Thousands) in Japan (2020-2034)
Table 17: Total Age-specific Cases of cUTI(in Thousands) in Japan(2020-2034)
Table 18: Total Pathogen-specific Cases of cUTI in Japan( (in Thousands) 2020-2034)
Table 19: Total Treated Cases of cUTI in Japan (in Thousands) (2020-2034)
List of Figures
Figure 1: Urinary System
Figure 2: Classification of UTI
Figure 3: The European Section of Infections in Urology classification of UTIs
Figure 4: Common Symptoms of UTIs
Figure 5: Pathophysiological aspects of complicated UTI and pyelonephritis
Figure 6: Algorithm for Diagnosis of cUTI
Figure 7: Algorithm for evaluating a woman with symptoms of Acute UTI
Figure 8: Epidemiology Methodology
Figure 9: Total Diagnosed-Incident Cases of cUTI in the 7MM (2020-2034)
Figure 10: Total Diagnosed-Incident Cases of cUTI progressed from uUTI in the 7MM (2020-2034)
Figure 11: Total Diagnosed Incident Cases of cUTI in the US (2020-2034)
Figure 12: Total Diagnosed Incident Cases of cUTI progressed from uUTI in the US (2020-2034)
Figure 13: Total Age-specific Cases of cUTI in the US (2020-2034)
Figure 14: Total Pathogen-specific Cases of cUTI in the US (2020-2034)
Figure 15: Total Treated Cases (across the line) of cUTI in the US (2020-2034)
Figure 16: Total Diagnosed-Incident Cases of cUTI in EU4 and the UK (2020-2034)
Figure 17: Total Diagnosed-Incident Cases of cUTI progressed from uUTI in EU4 and the UK (2020-2034)
Figure 18: Total Age-specific Cases of cUTI in EU4 and the UK (2020-2034)
Figure 19: Total Pathogen-specific Cases of Complicated Urinary Tract Infection in EU4 and the UK (2020-2034)
Figure 20: Total Treated Cases of cUTI in EU4 and the UK (2020-2034)
Figure 21: Total Diagnosed Incident Cases of cUTI in Japan (2020-2034)
Figure 22: Total Diagnosed Incident Cases of cUTI progressed from uUTI in Japan (2020-2034)
Figure 23: Total Age-specific Cases of cUTI in Japan (2020-2034)
Figure 24: Total Pathogen-specific Cases of cUTI in Japan (2020-2034)
Figure 25: Total Treated Cases of cUTI in Japan (2020-2034)